The FDA has approved the first liquid formulation of a prophylactic gout drug, colchicine oral solution (Gloperba, ROMEG Therapeutics). Gloperba 0.6 mg/5 mL is approved for prophylaxis in adults who have gout flares that are left untreated by existing therapies.
Gout is a form of arthritis affecting an estimated 8.7 million people in the United States, that is caused by elevated levels of uric acid in the bloodstream, with symptoms from the buildup of uric acid crystals in the joints. Symptoms